These included IGBP1, RNF39, FRMD1, INPPL1, FSCN2, NUBPL, UQCRQ, C12orf10, LINC00115, and LOC100129198; whereas, in pediatric RUNX1/RUNX1T1 AML patients, they included SHANK1, linc-RXFP2-1, SNORD9, and EGLN1. This evidence concerns the gene INPPL1 and acute myeloid leukemia.